A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines.
Article1 min read·Published Oct 2026

A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines.

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Oct 2026 · 1 min read

In brief

In brief

Systematic meta-analysis synthesizing published clinical trial data on SARS-CoV-2 vaccine safety profiles and immune responses. Reviews evidence from multiple databases to assess adverse event rates and immunogenicity outcomes across different COVID-19 vaccine platforms.

Written by the GCMD Library team from the article.

Ramy Shaaban

The presented meta-analysis (MA) aims at identifying the vaccine safety and immunogenicity in published trials about SARS-CoV-2 vaccines. All relevant publications were systematically searched and collected from different databases (Embase, Scopus, EBSCO, MEDLINE central/PubMed, Science Direct, Cochrane Central Register for Clinical Trials (CENTRAL), Clinical Trials.gov, WHO International Clinical…

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →